Pharmaceutical Chemistry Journal

, Volume 6, Issue 11, pp 724–733 | Cite as

Use of nonaqueous solvents to prepare injection solutions

  • P. V. Lopatin
  • V. P. Safonov
  • T. P. Litvinova
  • L. M. Yakimenko
Technology
Received:

Keywords

Organic Chemistry Injection Solution Nonaqueous Solvent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature cited

  1. 1.
    I. G. Andrianova and L. K. Bogomolova, Summary Reports of the Leningrad Scientific-Research Institute on Blood Transfusion [in Russian], Leningrad (1962), p. 55.Google Scholar
  2. 2.
    F. A. Zhoglo and B. V. Kocharovskii, Farmatsevtich. Zh., No. 5, 3 (1970).Google Scholar
  3. 3.
    B. V. Kocharovskii, in: Material of the All-Union Scientific Conference on Improving Manufacture of Medicines and Medical Preparations [in Russian], Tashkent (1969), p. 19.Google Scholar
  4. 4.
    J. Dekanski and R. N. Chapman, Brit. J. Pharmacol.,8, 271 (1953).Google Scholar
  5. 5.
    L. Krowczynski, Technologia lekow perenteralnych, Warsaw,122, 154 (1968).Google Scholar
  6. 6.
    S. Casadio, in: Technologia farmaceutica Cisalpino (1960), p. 869.Google Scholar
  7. 7.
    L. P. Volkovinskaya, T. I. Fabrichnaya, and A. M. Pozharskaya, Khim.-Farm. Zh., No. 11, 60 (1968).Google Scholar
  8. 8.
    M. A. Seidenfeld and P. J. Hanzlick, J. Pharmacol. Exp. Ther.,44, 109 (1932).Google Scholar
  9. 9.
    J. R. Hickman, Pharm. (London),17, 256 (1965).Google Scholar
  10. 10.
    R. T. Brittain and P. F. D'Arcyp, Toxicol. Appl. Pharmacol.,4, 738 (1962).Google Scholar
  11. 11.
    H. J. Brass, J. Am. Pharm. Ass., 2nd ed.,4, 310 (1943).Google Scholar
  12. 12.
    T. H. McGavack and M. Vogel, J. Lab. Clin. Med.,29, 1256 (1944).Google Scholar
  13. 13.
    A. Ganz, H. Fujemou, M. Penna, et al., Proc. Soc. Exp. Biol. (N. Y.),95, 349 (1957).Google Scholar
  14. 14.
    M. Chalabala, Vyroba injeksi, 14 (1964).Google Scholar
  15. 15.
    M. Kh. Gluzman, B. I. Dashevskaya, and P. I. Onishchev, Med. Prom. SSSR, No. 4, 14 (1965).Google Scholar
  16. 16.
    Cheng-chun Lee and R. C. Anderson, Toxicol. Appl. Pharmacol.,4, 206 (1962).Google Scholar
  17. 17.
    J. I. Bodin and A. Taub, J. Am. Pharm. Ass., sci. ed.,44, 296 (1955).Google Scholar
  18. 18.
    T. Higuchi and J. L. Lach, ibid.,43, 465.Google Scholar
  19. 19.
    S. Linde, Svensk. Farm. T.,65, 181 (1961).Google Scholar
  20. 20.
    V. P. Gusyakov, N. N. Likholet, et al., Farmatsevtichn. Zh., No. 6, 56 (1968).Google Scholar
  21. 21.
    V. P. Gusyakov, A Study of the Solubilization of Difficultly Soluble Medicines. Author's Abstract of Doctoral Thesis [in Russian], L'vov (1969).Google Scholar
  22. 22.
    D. Kuttel, Gyogyszrészet,5, 325 (1961).Google Scholar
  23. 23.
    D. Kuttel, Pharm. Zentralh.,102, 115 (1963).Google Scholar
  24. 24.
    D. Kuttel, Gyogyszerészet.,7, 131 (1963).Google Scholar
  25. 25.
    V. N. Banshchikov, A. M. Tentsova, and A. S. Azhgikhin, Farmatsiya, No. 4, 70 (1967).Google Scholar

Copyright information

© Consultants Bureau 1973

Authors and Affiliations

  • P. V. Lopatin
    • 1
  • V. P. Safonov
    • 1
  • T. P. Litvinova
    • 1
  • L. M. Yakimenko
    • 1
  1. 1.Institute of Experimental and Clinical OncologyAcademy of Medicinal Sciences of the USSRMoscow

Personalised recommendations